The 6th Virtual Clinical Trial Conference, a trusted conference on decentralized trials, invites professionals, clinicians, and vendors of the pharma, medical device, and biotech fields. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company focuses on meeting the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.  As clinical trials are switching to more decentralized and hybrid models, more information on the successful implementation and the future scope of clinical trials must be discussed and analyzed over a collaborative platform. At the 6th Virtual Clinical Trials Conference, hear and learn from discussions about actual clinical trial case studies that are implementing DCT’s. Attendees will deep dive into the intricacies involved in SOP’s and discuss the future of these trials with leading industry leaders. Dignitaries and eminent personalities of the pharma and healthcare industries will reside as speakers to discuss the exclusive insights on the successful implementation of decentralized trials and what challenges can be overcome in data compliance, regulatory compliance, and patient retention. These pharma industry professionals and experts will offer all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, and applying new technologies along with novel strategies and viewpoints. The 2-day event platform can be leveraged by professionals in clinical operations, research, digital health, scientific affairs, technical solutions, strategy, innovation, quality, and planning officers, as well as medical managers, directors, auditors, and medical advisors. The agenda of the conference focuses is:

• Engaging patients the right way by ensuring a reduction in patient burden thereby improves retention and reduces the project cost
• Allow for speedy data accumulation and quick timelines by doing away with on-site visits
• Reduce workload for clinical trial sites for better time and cost efficiencies by monitoring regulatory and process improvements
• Incorporate efficient processes into the trial design to overcome the laxity in the trial process
• Improve safety monitoring, safety producers, and follow up outcomes

In addition, attendees can gain immense knowledge about the various facets of decentralized clinical trials. Explore the most innovative ways to conduct clinical trials, measure their success and understand the next-generation clinical trial data management. This conference is taking place at The Inn at Penn, a Hilton Hotel, Philadelphia, US on May 18-19, 2022 In Person. To learn more, please visit https://dgevents.com/event/virtual-clinical-trials/.

• Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan
• The debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape products
• RWB expects to release its full-year 2021 results on May 2, with the management hosting a conference call on May 3

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator on a mission to become the most recognizable cannabis company in the United States, is celebrating the fulfillment of its promise to consumers to introduce a steady stream of new products and consumption options to satisfy demand in Michigan, recently announcing it will roll out the Platinum Vape(TM) (“PV”) Live Resin in Michigan. The company, working in conjunction with its wholly owned subsidiary RWB Michigan LLC, will make the product available in nearly 400 Michigan dispensaries in due course (https://ibn.fm/qlaxi). The debut marks RWB’s line expansion into the higher-margin Live Resin Vapes segment and also represents its inaugural product in Michigan beyond the popular distillate vape products. The company is committed to releasing many more products in the future. The PV Live Resin delivers a lush flavor profile and rich potency experience, thanks to its ability to capture and preserve the terpenes and trichomes of RWB’s premium cannabis strains. (Live resin is a cannabis concentrate created using fresh flower.) A compact product with a myriad of consumption options, the PV Live Resin packs all the benefits of the cannabis flower and more than 80 cannabinoids that synergistically work to enhance the plant’s therapeutic properties. Red White & Bloom expects PV Live Resin to become popular with consumers owing to the trust they have in the PV brand. With the PV Live Resin, which was previously only available in Oklahoma and California, RWB aims to tap into the growing U.S. live resin market. According to Greentank, live resin sales increased 86% between 2020 and 2021 (https://ibn.fm/1lsdx). But RWB holds that this growth is only the tip of the iceberg. “We believe that this is just the tip of the iceberg for the live resin opportunity since so many new cannabis consumers are totally unfamiliar with live resin and migrate to it once they learn more about cannabis and discover live resins’ many advantages,” company CEO Brad Rogers said. Red White & Bloom is simultaneously streamlining its seed-to-sale processes and speeding up the development and go-to-market timelines for new products. According to Rogers, the company has already started expanding the distribution of its PV branded products, including the new PV Live Resin line, with the PV products now available in nearly 400 of Michigan’s 460+ dispensaries. Meanwhile, the company announced it will release its end-year (2021) financial results, subsequent events, and management discussion and analysis (“MD&A”) on Monday, May 2, after markets close. The following day, Tuesday, May 3, company Rogers will host a conference call in which he will discuss RWB’s quarterly results, operations, and upcoming events. Rogers will also join the management team in fielding questions from stakeholders and investors (https://ibn.fm/lPOaG). The 2021 results will draw the curtains on an eventful year that saw the company report $11.8 million in revenue in Q1 2021 and $13.3 million in Q2 2021 (https://ibn.fm/0m1Xj). In Q3 2021, Red White & Bloom’s revenue was up 93% year-over-year to $11.8 million from $6.1 million in Q3 2020 (https://ibn.fm/Kh8fb). Already, the company’s cumulative revenue from the first nine months of the 2021 fiscal year (~$36.9 million) has surpassed the full year 2020 revenue ($23.3 million) (https://ibn.fm/PZc5X), setting the stage for what is likely to be a record-breaking year for Red White & Bloom. The 2021 financial year also saw the announcement of key milestones, including the acquisition of cultivation facilities in Apopka, Florida and Sanderson, Florida; the opening of a production facility at the Sanderson property; receipt of Adult Use prequalification status in Michigan and approval from the Florida Department of Health, Office of Medical Marijuana Use; and more. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs
• This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S.
• It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwide
• Over the 2022 calendar year, the company seeks to also pursue regulatory and commercial advancement

In 2016, Lexaria Bioscience (NASDAQ: LEXX) received its first United States patent grant and over the years, the company has been aggressive at broadening its patent suite, a move which it has attributed to refining the patent claims via further US provisional and utility patent filings. More patents mean more intellectual property and enhanced ability to pursue regulatory and commercial progress. As of March 2022, Lexaria had 24 patents, having been granted its latest one in Australia, titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof” (https://ibn.fm/s11pt). In what marks another significant milestone for Lexaria, it has announced receiving its first-ever patent for the use of DehydraTECH(TM) technology in the enhanced delivery of antiviral drugs. Patent 11,311,559, titled “Compositions and Methods for Enhanced Delivery of Antiviral Agents,” becomes the 10th granted in the U.S. “This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology,” noted Lexaria’s Chief Executive Officer (“CEO”), Chris Bunka (https://ibn.fm/N14Vy). Lexaria had earlier announced and demonstrated how effective remdesivir and ebastine processed with DehydraTECH were against inhibiting COVID-19/SARS-CoV-2. It also separately proved that antiviral drugs processed with DehydraTECH reached peak blood concentration levels that were double those of non-DehydraTECH-processed alternatives. In addition, the company showed that the overall volumes of drugs delivered into the bloodstream were up to triple that of non-DehydraTECH-processed variants. Lexaria remains focused on exploring DehydraTECH’s full potential. So far, it is exploring its potential usage in treating heart disease and hypertension. It is also separately conducting studies on oral nicotine delivery, antiviral delivery, epilepsy, hormone replacement, rheumatoid disease, dementia, and diabetes, most of which will define clinical studies for the 2022 calendar year and beyond. The company’s management has even noted that the company will continue to see significant milestones in using DehydraTECH, specifically DehydraTECH-CBD, for potential hypertension and heart disease treatment, among other conditions. “We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease, and diabetes,” noted Mr. Bunka back in February (https://ibn.fm/DwQNL). Most notably, Lexaria’s management reckons that clinical studies for 2022 are on schedule and will play an integral role in receiving even more patents for its DehydraTECH technology. “The approval (by the independent review board earlier this year) sets the stage for the HYPER-H21-4 study that could define Lexaria’s future. DEM-A22-1, expected to begin in July 2022, will evaluate DehydraTECH-CBD with or without nicotine for the potential treatment of dementia. Lexaria also plans to execute on the RHEUM-A22-1 and DIAB-A22-1 studies, scheduled for October and November, respectively…” said Mr. Bunka. In addition to the 25 granted patents, Lexaria has over 50 pending patents worldwide and is committed to growing its patent portfolio for the benefit of its shareholders, clients, and patients dealing with various conditions that could benefit from its DehydraTECH technology. “This new patent adds to our existing suite of granted patents in the EU, the U.S., India, Japan, and Australia, and continues to build value for Lexaria shareholders and clients,” Bunka noted. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Once ignored by investors and known mostly for its catchphrase treated as a punchline, Lifeline eventually sold to Royal Philips Electronics for $690 million
• InnerScope Hearing Technologies is making its presence known in the affordable hearing aid market, including a memorable commercial and a rapidly expanding list of physical and online retailers
• InnerScope is expanding at a breakneck pace, making acquisitions, and forging partnerships, adding manufacturing and R&D facilities, customers, new product development capabilities, and a comprehensive customer service platform

“Can you hear me now?” “Liberty Biberty.” Some advertisements leave an indelible impression on people, often after seeing a commercial just one time. Unfortunately, most people probably associate that type of success with a mega-company sporting 10-figure marketing budgets. However, that is not always the case, and companies that get your attention as an upstart deserve a closer look now. Consider Lifeline Systems, the personal emergency response system conceived by Andrew Dibner. Dozens of venture capital firms turned the company down in its early days. The take-flight moment came in the late 1980s with a television commercial featuring actress Dorothy McHugh lying on the ground pressing the Lifeline button and saying, “I’ve fallen, and I can’t get up!” Suddenly, everyone knew about the brand. Lifeline went public in 1983, and while generating $100+ million in sales in 2006, it was acquired by Royal Philips Electronics for $690 million. Upstart InnerScope Hearing Technologies (OTC: INND) may have struck gold with the commercial for its Hearing Assist hearing aids, where the son repeatedly says, “I love you, Dad,” only to become disgruntled by his father’s hearing loss and the incessant response of “What?” However, that changes when the dad gets HearingAssist hearing aids, and the two share a heartfelt moment because he could finally hear his son’s kind words. It’s one of those commercials that is hard to forget and jumps right to mind with any discussion on hearing aids. InnerScope’s portfolio of products include FDA-registered Direct-to-Consumer (“DTC”) self-adjusting hearing aids, self-adjusting Personal Sound Amplifiers Products (“PSAPs”), doctor-formulated dietary hearing and tinnitus supplements, and assorted ear and hearing health-related products. InnerScope sells its hearing aids through multiple channels, including its eCommerce site www.iHEARdirect.com and its partners www.FSAstore.com, www.HSAstore.com, and www.WellDeservedHealth.com. The latter three sites are curated to meet demand from consumers enrolled in flexible spending accounts, health saving accounts, and employers’ health incentive plans. The company also has a strong retail presence through the acquisition of HearingAssist last year. The acquisition catapulted InnerScope to being Walmart’s largest selling brand of hearing aids, with over 500,000 sold to nearly 400,000 customers. HearingAssist products are sold in 757 Walmart locations, and online at www.Walmart.com, and have generated aggregate sales of approximately $72 million. About a month ago, another milestone was reached with a deal struck with Rite Aid to begin selling HearingAssist’s hearing aid care and assorted hearing aid batteries, earwax removal ear spray, and a Wireless Neckband TV Listener Hearing Amplifier on www.RiteAid.com. That was followed this past week by a wholesale vendor agreement with Best Buy to start offering HearingAssist products in the U.S. and Puerto Rico at the big-box giant’s brick and mortar retail locations, as well as online at www.BestBuy.com. The retail and online list has grown impressively to include the aforementioned plus, to name a few, Giant Eagle, Amazon.com, Hy-Vee, Food City, and Hartig Drug stores. With the HearingAssist brand becoming more and more recognizable, InnerScope is making moves to better serve customers, as well as expand its physical and digital footprints to attract more customers. These efforts include launching a comprehensive customer service portal complete with free access to doctors and hearing specialists to answer questions and the installation of dozens of hearing kiosks in stores of major retailers and pharmacy chains. Elsewhere, InnerScope acquired iHear Medical Inc, a DTC cloud-based provider of hearing solutions, holder of 40+ patents, and owner of an FDA-registered manufacturing and R&D facility. R&D is part of the strategy, which is now supported by a partnership with semiconductor company Atlazo to work on next-generation devices. There are at least 70 million people in North America suffering from some level of hearing impairment, yet effective solutions elude most due to prohibitive pricing. The industry is changing to bring lower pricing and different payment solutions, so hearing aids are far more inclusive. The timing is perfect considering the bipartisan support on Capitol Hill to hurry up and get the Over-the-Counter Hearing Aid law enacted. Overlooked by most (INND trades at half a penny per share and a $33 million valuation), the next chapter is being written in which InnerScope will command a much stronger presence in the space. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Earlier studies show that CYB004 via inhalation may solve existing challenges and support a clinical path forward for this important therapeutic
• Cybin is currently developing CYB004 for the treatment of anxiety disorders
• The new chemical entity is covered by a patent issued earlier this year

Cybin (NEO: CYBN) (NYSE American: CYBN) has released data from a pharmacokinetic study focused on evaluating CYB004, the company’s proprietary deuterated dimethyltryptamine (“DMT”) molecule (https://ibn.fm/nyCj8). The study analyzed delivery methods of CYB004, and showed initial data indicates significant advantages over Intravenous (“IV”) and Inhaled DMT. “In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues,” said Cybin CEO Doug Drysdale. “However, known side effects like disorientation and anxiety and its mode of administration have historically hindered its use and availability. CYB004 via inhalation may solve these challenges and finally support a clinical path forward for this important therapeutic.” According to the report, inhaled CYB004 showed significant advantages over both IV DMT and inhaled DMT, including longer duration of action and improved bioavailability. The study also indicated that inhaled CYB004 showed an onset of effect and dose profile similar to IV DMT. “These data may support the potential for inhalation as a viable and well-controlled delivery system of therapeutic psychedelics,” the announcement states, noting that Cybin is currently developing CYB004 for treatment of anxiety disorders. Specifically, the company reported that, based on preclinical results, inhaled CYB004 demonstrated:

• Approximately 2,000% improved bioavailability compared with orally administered DMT, which is known to have limited to no oral bioavailability
• Approximately 41% improved bioavailability compared with inhaled DMT
• Approximately 300% longer duration of effect when compared with IV DMT, indicating potential to extend the therapeutic window
• Rapid onset of effect and low variability equivalent to IV DMT

A new chemical entity, CYB004 is covered by a patent issued by the U.S. Patent and Trademark Office earlier this year. The patent allows claims that include a range of deuterated forms of DMT and 5-MeO-DMT. The composition of matter patent is expected to expire in 2041 before consideration of any patent term extensions. “As part of Cybin’s overall mission to create safe and effective psychedelic-based therapeutics, inhaled CYB004 is being developed to potentially overcome the limitations of IV DMT and become an important treatment option for anxiety disorders for patients and physicians,” stated Drysdale. He also noted that the company plans to submit a regulatory filing for a pilot study in the coming weeks. “Cybin’s approach to psychedelic drug development enables the control of many biological factors, including improving the way a drug is metabolized and managing some adverse effects. “In its natural form, DMT is unstable and not orally bioavailable,” Drysdale concluded. “Based on these preclinical studies, we believe CYB004 has the potential to overcome these issues. These results also provide strong evidence that an inhaled delivery mode may be able to address the limitations of IV DMT and could be widely applicable to a variety of psychedelics.” Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Clean energy solutions innovator FuelPositive Corp. is developing a scalable, containerized, modular means of producing green ammonia for customers in the agriculture industry
• The agriculture industry uses 80 percent of the current global supply of ammonia for fertilizer
• FuelPositive’s IP is designed to produce 300 kilograms per day of liquid anhydrous carbon-free ammonia — the amount needed to fertilize and power a 2,000-acre farm
• FuelPositive is initially targeting Canadian farmers as the customers for its green ammonia solution, and has established research partnerships to determine how to most effectively roll out its modules in order to meet farmers’ needs

Clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), is nearing the rollout of its first onsite demonstration system for producing green, hydrogen-dense anhydrous ammonia, with an initial goal of helping the agricultural industry buffer against the difficulties of supply chain interruptions and improving the industry’s impact on the climate. Green ammonia is gaining gravitas as a clean energy solution to environmental pollution that is believed to be altering climates worldwide. Chemical & Engineering News describes the process pioneered a century ago to produce ammonia from hydrogen and atmospheric nitrogen as perhaps the biggest global problem ever solved by chemistry, due to ammonia’s utility as high volume-producing fertilizer and now as a means of producing hydrogen for energy or for use in energy generation in its own right. “Up to this point, we have made a business by selling the nitrogen value of the molecule,” ammonia producer CF Industries’ CEO Tony Will told the magazine (https://ibn.fm/cYCpk). “What’s really exciting about this is now there is an opportunity and a market that values the hydrogen portion of the molecule.” FuelPositive is helping to pioneer such scientific development by rolling out its scalable, containerized “plant-in-a-box” that uses a carbon-free process to make pure green ammonia. The company’s first demonstration system will launch on a farm in Manitoba, Canada, later this year, followed by two additional demonstration systems in coming months (https://ibn.fm/CXxA5). The system is designed to produce 300 kilograms per day of liquid anhydrous carbon-free ammonia, which FuelPositive describes as the approximate amount needed to fertilize and power a 2,000-acre farm. The technology is already proven in the lab and the company is now moving it into real world application. “Ammonia can be produced with natural elements such as the sun, air and water, resulting in a sustainable output. Of course, since the plant operates on renewables, it needs a constant supply of energy, so the location needs to be considered carefully – it is best to build a green ammonia plant near the energy source to optimize the financial model,” one author states in a recent issue of Fertilizer Focus magazine (https://ibn.fm/E8uNZ). But the shipping container-sized models designed by FuelPositive for portability mean that the plant can effectively be delivered easily to the end user under a decentralized methodology that grants the end user a great deal of control over the product. In keeping with FuelPositive’s focus on serving the agricultural industry, which consumes 80 percent of the current global supply of ammonia for fertilizer, the company announced March 29 that Pollara Strategic Insights will become a corporate market research partner and University of Guelph (Ontario) associate research professor Leith Deacon will provide further advisement on data-based rural planning to help FuelPositive most effectively reach its target consumer (https://ibn.fm/Z46od). “It’s important to recognize that if you’re designing a product for farmers, you need to make sure the product is reflective of farmers’ realities. The only way to know what they need and want is to ask them. I’m excited to see that FuelPositive is engaging directly with farmers and taking its decision-making so seriously,” Deacon stated. “Our team has extensive experience in the agriculture space, especially in terms of sustainable and regenerative farming. We are conducting qualitative interviews and quantitative surveys across a robust sample of Canadian farmers to extract deep insights and direction for the Company to consider when making its decisions,” Pollara’s founder and chief strategist Don Guy added. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• The bitcoin 2022 convention took featured over 450 speakers, with more than 3,000 companies represented during the event
• LQwD currently has 10 active nodes on the Lightning Network – France, England, Sweden, Singapore, Italy, Indonesia, Germany, Ireland, India and the US
• By 2030, the Lightning Network could see more than 700 million users leading to as many as 364 trillion transactions per year

Presented by Cash App, the biggest bitcoin event in the world (bitcoin 2022) took place April 6-9, 2022, in Miami, Florida. The four-day event included Industry Day (April 6), the Main Convention (April 7 & 8), and the first-ever Bitcoin music festival Sound Money Fest (April 9). Over 35,000 attendees took advantage of the insight provided by over 450 speakers at the convention, which was sponsored by over 400 investors with more than 3,000 companies represented. The packed agenda included Q&A sessions, strategy, and even a Lightning Network Report presented by Torbjørn Bull Jenssen, CEO of Nordic cryptocurrency powerhouse Arcane Crypto (https://ibn.fm/KZ23S). Expanding at a fast rate, the Lightning Network has changed the way that transactions are handled across the blockchain. Many companies have leveraged technology that overlays the layer 2 payment protocol layered on top of a blockchain-based cryptocurrency like bitcoin or Litecoin. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company creating enterprise-grade infrastructure to drive bitcoin adoption, released a proprietary platform as a service (“PaaS”), https://lqwd.tech/, in November 2021, allowing users to send and receive payments quickly using the Lightning Network. LQwD has invested its own bitcoin in the Lightning Network – with 10 active nodes spanning multiple geographic locations. Currently, LQwD has nodes operating in France, England, Sweden, Singapore, Italy, Indonesia, India, Germany, Ireland, and the United States. Current LQwD Lightning Node statistics, as of April 25, 2022:

• US-West
  • Capacity: 5.689273640 BTC (US $224,462.72)
  • Channel Count: 106
• Ireland
  • Capacity: 0.380000330 BTC (US $14,992.41)
  • Channel Count: 8
• Germany
  • Capacity: 1.360000160 BTC (US $53,657)
  • Channel Count: 25
• Indonesia
  • Capacity: 1.835046080 BTC (US $72,399.3)
  • Channel Count: 35
• Italy
  • Capacity: 0.250000250 BTC (US $9,863.43)
  • Channel Count: 5
• Singapore
  • Capacity: 1.344596260 BTC (US $53,049.26)
  • Channel Count: 23
• Sweden
  • Capacity: 0.350000440 BTC (US $13,808.8)
  • Channel Count: 7
• England
  • Capacity: 0.470000150 BTC (US $18,543.23)
  • Channel Count: 11
• France
  • Capacity: 2.130782200 BTC (US $84,067.18)
  • Channel Count: 40
• India (launched April 19, 2022)
  • Capacity: 0.050000000 BTC (US $ 1,972.68)
  • Channel Count: 1

To follow LQwD’s presence on the Lightning Network, visit www.1ML.com. When the new nodes were released, CEO Shone Anstey shared the company’s insight, underlying that the launch firmly positions LQwD to increase its overall value on the network. “Being a leading Lightning Network infrastructure and transaction facilitator has a lot of value: First, Lightning Network’s early-movers (like us) are best positioned to strategically expand our position on the network,” Anstey explained (https://ibn.fm/MHaj1). “Second, the more nodes LQwD establishes worldwide; the more transactions can be routed through our node network. And each transaction represents a routing fee.” The Lightning Network has seen constant growth in the past year and is expected to continue this upward trend, along with the global cryptocurrency market. According to an October 2021 report by Arcane Research titled “State of Lightning,” the Lightning Network could see more than 700 million users by 2030, leading to as many as 364 trillion transactions per year. Meanwhile, the global cryptocurrency market is expected to reach US $4.94 billion by 2030, growing at a CAGR of 12.8% from US $1.49 billion in 2020. Growth drivers include the need for increased transparency in payment systems and the untapped potential within emerging economies (https://ibn.fm/ZKh3B). For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Correlate will set up a 908-kW rooftop solar project at Continental Envelope’s Geneva, Illinois headquarters
• Once completed, this project will provide over 1.2 million kilowatt-hours of clean energy and power 20-25% of the facility’s overall energy needs
• Engineering work has already commenced on the project, with construction projected to start in the summer of this year
• Correlate’s management is confident that once done, this project will showcase what the company can do and how achievable energy forward-thinking is for manufacturing businesses of all kinds and sizes across the world

Since its inception, Correlate Infrastructure Partners (OTCQB: CIPI) has created an industry-leading energy solution and financing platform focusing on the commercial and industrial sectors. This stems from the fact that there is a significant untapped opportunity in these two areas, starting with the much-needed clean-energy upgrades necessary to achieve U.S. 2050 carbon goals. In an assessment conducted by the company, it has been established that, for the carbon goals to be achieved, at least 200,000 commercial buildings should be retrofitted every year until that date, representing a 5-10 time increase over the 2022 industry process run rate. In a move that seeks to bring the company closer to achieving this goal, it has partnered with Continental Envelop to set up a 908-kW rooftop solar project which, once completed, will power 20-25% of the facility’s overall energy needs. Continental Envelope manufactures 2 billion envelopes every year and counts some of the leading brands in the U.S. as clients, including Netflix, AT&T, Capital One, and American Express. The company’s headquarters, located in Geneva, Illinois, where the solar project will be located, is 84 years old, with the company itself being in operation since the 1930s (https://ibn.fm/QX2pL). Given its efforts to embrace and adopt clean energy, Continental Envelope has been termed one of the greenest envelope factories in the country. The move to install the rooftop solar project only seals that title and sets the company apart from its peers. Engineering work on the solar project kicked off on April 18, 2022, with construction estimated to start in the summer of this year. The project will feature 1667 solar energy modules with the capacity to produce over 545 watts each. Once done, the entire project will provide over 1.2 million kilowatt-hours of clean energy and offset over 18,849 tons of carbon dioxide over the next 20 years, according to the EPA’s Greenhouse Gas Equivalencies Calculator. “Correlate Infrastructure Partners is pleased to move forward with the Continental Envelope solar project, which will contribute to the modernization of their electricity generation supply and improve its sustainability,” noted Correlate’s Chief executive Officer (“CEO”), Todd Michaels. “We are grateful to partner with this innovative family business as we lead the printing and manufacturing industry toward clean, efficient, and renewable generation without compromising reliability,” he added. Correlate’s management is confident that this project will show how achievable energy forward-thinking is, not just for printing but also for manufacturing businesses worldwide. It also believes that it will showcase the company’s capacity to execute a project of this size, plan and create an innovative building health program of activities designed to set companies on the path toward Net-Zero. “This solution for Continental envelope is a demonstration of Correlate’s commitment to designing and building customer-centric energy projects that not only deliver profitable sustainability, but also leverage local and national incentives and technology like solar and storage to provide meaningful financial benefit to our customers’ bottom line,” noted Jason Loyet, the Director of Solar Energy & Storage with Correlate For more information, visit the company’s website at www.CorrelateInfra.com. NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• SPYR Inc., through its wholly owned subsidiary Applied Magix, develops and resells Apple ecosystem-compatible products
• Applied Magix enabled SPYR to enter the rapidly growing smart-home and smart-car markets
• SPYR offers a wide array of products such as MagixDrive, a secure video camera with iCloud storage, MagixBlock USB DataBlocker, MagixCharge Dual USB-C Car Charger, and more
• With these products, SPYR targets Apple’s following of loyal consumers, who have a limited selection of HomeKit-enabled products from which to choose

As the smart homes and smart cars markets heat up, generating much interest from consumers and manufacturers alike, they have attracted both established tech behemoths, including Amazon.com Inc. (NASDAQ: AMZN), Google Inc., Microsoft Corporation (NASDAQ: MSFT), Intel Corporation (NASDAQ: INTC), and Apple Inc. (NASDAQ: AAPL), as well as growing technology companies such as SPYR (OTCQB: SPYR). According to a recent editorial piece entitled “Smarter Homes, Smarter Cars, Smarter People,” SPYR, through its strategically acquired wholly-owned subsidiary Applied Magix Inc., is specifically focusing its attention on providing smart hardware and software products for Apple’s large following of loyal consumers (https://ibn.fm/6404o). In doing so, the company offers a solution to a problem that has seen Apple fall behind competitors such as Google and Amazon with its comparably limited portfolio of HomeKit-enabled products. HomeKit is Apple’s software framework – akin to Google Home (Google Assistant) and Amazon Alexa – that enables iOS and iPadOS devices to connect to and control smart-home appliances. Applied Magix, a registered Apple developer and reseller of Apple ecosystem-compatible products acquired in 2020, has enabled SPYR to selectively target Apple consumers, who are renowned for being extra passionate about the brand as well as their willingness to pay a premium for Apple’s quality products and seamless integration of the closed ecosystem. According to the latest statistics, this ecosystem comprises 1.8 billion active iPhones, an increase from 1.65 billion active iPhones in January 2021 (https://ibn.fm/GEnb3). The subsidiary’s first product, the MagixDrive, is an adapter that creates a wireless experience enabling users to enjoy all the perks of CarPlay, such as streaming services, Siri voice commands, navigation, apps, and more, without having to connect their phones to a cable. “This is a golden opportunity for Applied Magix to become front and center with Apple users, capture market share, and create a loyal following,” the Editorial reads. And to better improve these chances, Applied Magix is actively marketing MagixDrive through a commercial campaign, whose airing schedule was expanded in February to grow the product’s reach and visibility (https://ibn.fm/TLiHk). In addition to MagixDrive, Applied Magix also offers additional products, including a secure video camera with iCloud storage, MagixBlock USB DataBlocker, MagixCharge Dual USB-C Car Charger, and more (see below for a complete list). With these products, SPYR and Applied Magix target multiple multi-billion-dollar markets that are projected to continue growing well into the future. For instance, Grand View Research anticipates the global smart home security cameras market will grow at a 15.7% CAGR, reaching $11.89 billion by 2027 (https://ibn.fm/h1T6H). Likewise, Allied Market Research projects the global connected car market will grow to $225.16 billion by 2027, up from $63.03 billion in 2019, representing a 17.1% CAGR (https://ibn.fm/fHOoW). “SPYR and Applied Magix management, including a newly formed advisory board, are initially setting their sights on Apple consumers throughout North America and Europe, in other words, those with the largest profit potential, which should translate into corporate value. To reach these consumers, Applied Magix leverages strong relationships with third-party distributors and influences of Apple consumer products,” the Editorial reads. To view the full Editorial, please visit: https://ibn.fm/FBmke To listen to the Network News Audio broadcast covering the Editorial, please visit: https://ibn.fm/Gxxk4 For product information, please see the Applied Magix website at https://AppliedMagix.com, or specific product sites:

• MagixDrive Wireless CarPlay Adapter –https://appliedmagix.com/MagixDriveBundle
• HomeKit Secure Video Camera with iCloud Storage – https://appliedmagix.com/HomeKitCamera
• Multipurpose Sensor with Alarm –https://appliedmagix.com/HomeKitAlarmSensor
• Environment and Motion Sensor –https://appliedmagix.com/HomeKitMotionSensor
• Window and Door Contact Sensor – https://appliedmagix.com/HomeKitContactSensor
• MagixBlock USB DataBlocker – https://appliedmagix.com/MagixBlock
• MagixCharge Dual USB-C Car Charger – https://appliedmagix.com/MagixCharge

For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

Explore the world of cannabis and navigate the immense networking opportunities offered at the O’Cannabiz Conference Expo & Awards from June 1-3, 2022. This event offers a phenomenal stage for traders, cultivators, marketers, regulators, researchers, and cannabis businesses in the region to get recognition on the global forum, amongst the stalwarts of the cannabis space. This year, the conference is being organized by O’Cannabiz Conference Expo & Awards as a physical event at the International Centre- Hall#5, Ontario, Canada, after being canceled last year due to COVID-19. The Conference and Expo will be held at the 50,000 sq. ft hall with 3500+ attendees networking in 70+ interactive sessions, with 180+ industry leaders speaking about cannabis trading, laws and regulations, the scope and future of industries, as well as the compliance in Canada. The participants will be welcomed by a Red Carpet Royalty Cocktail Reception, followed by a dinner and awards ceremony, and an after-party session with VIP networking for exhibitors, sponsors, and delegates. The event group is a pioneer in hosting high-tech events to open networking avenues among traders, businesses, enthusiasts, and government bodies across the entire spectrum of industries. The event will also showcase O’Cannabiz Industry Gala Awards, hosted by Gerry Dee, where the team will honor Tommy Chong with a Lifetime Achievement Award along w ith his celebrity interview. The next day is followed by exhibits and respective booths where cannabis industries and retailers can showcase their business ideas and get discovered by potential investors. Seek in-depth knowledge and insights from the spectacular line-up of speakers and become a part of engaging sessions where these influencers will discuss a plethora of topics across the entire spectrum of cannabis industries and trade. At the O’Cannabiz Conference Expo & Awards, the teams take up the initiative of connecting investors, traders, retailers, exhibitors, and regulators of cannabis use and trade over a common stage. They have organized global trade summit initiatives and are experienced to handle government entities and have worked with the Canadian government. The Conference will include sessions on the Psychedelic trade, its regulations, laws, and viability from a commercial standpoint. Attendees will also get an opportunity o to connect with investors, peers, and influencers during the networking breaks. They can leverage this opportunity to connect ad develop long-term ties with business associates and discover new prospects. To know more, please visit https://ocannabiz.com/.